Hypertension Clinical Trials in Dallas, Texas

11 studies are recruiting for hypertension in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

    The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.

    Stage
    Not phased
    Ages
    18 to 100
    Site
    UT Southwestern Medical Center, Dallas, Texas
    Locations
    21 in total
    Run by
    Zeenat Qureshi Stroke Institute
  2. EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

    This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglif…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Soltero Cardiovascular Research Center, Dallas, Texas
    Locations
    1142 in total
    Run by
    Boehringer Ingelheim
  3. SPYRAL GEMINI Pilot Study

    The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Baylor Heart & Vascular Hospital, Dallas, Texas
    Locations
    18 in total
    Run by
    Medtronic Vascular
  4. Global Paradise System US Post Approval Study

    The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Dallas VAMC, Dallas, Texas
    Locations
    46 in total
    Run by
    ReCor Medical, Inc.
  5. Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

    The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adj…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Clinical Trial Site, Dallas, Texas
    Locations
    1190 in total
    Run by
    Alnylam Pharmaceuticals
  6. BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

    A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Baylor Scott & White Research Institute, Dallas, Texas
    Locations
    131 in total
    Run by
    Orchestra BioMed, Inc
  7. Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

    The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic ner…

    Stage
    EARLY_Phase 1
    Ages
    18 to 55
    Site
    University of Texas Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  8. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…

    Stage
    Not phased
    Ages
    0 to 20
    Site
    University of Texas-Southwestern Medical Center Dallas, Dallas, Texas
    Locations
    52 in total
    Run by
    Duke University
  9. A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

    The study will be a multi-center, randomized clinical trial to evaluate the safety and efficacy of using the Zona Plus handgrip therapy device compared to the use of an auditory relaxation therapy for treatment of high blood pressure and hypertension in subjects who are not currently taking antihyp…

    Stage
    Not phased
    Ages
    22 and older
    Site
    Zenos Clinical Research, Dallas, Texas
    Locations
    10 in total
    Run by
    Zona Health, Inc
  10. Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

    The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

    Stage
    Not phased
    Ages
    18 to 60
    Site
    UT Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  11. Preventing Cognitive Decline by Reducing BP Target Trial

    The PCOT study is a multi-site randomized trial of patients 70 years or older with high BP. The main goal of the study Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) is to conduct a large pragmatic clinical trial (PCT) to test the hypothesis that patients who receive care with a co…

    Stage
    Not phased
    Ages
    70 and older
    Site
    UT Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.